APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

NCT02911961 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Due to lack of enrollment and organizational desire to focus recruitment efforts on other studies.

Conditions

Interventions

Sponsor

Denver Health and Hospital Authority

Collaborators